{"filing":{"accession_number":"0001568651-26-000074","cik":"0001568651","ticker":"OSCR","company_name":"Oscar Health, Inc.","form":"8-K","filing_date":"2026-09-16","report_date":"2026-09-16","primary_document":"oscr-20260916.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1568651/000156865126000074/oscr-20260916.htm"},"events":[{"id":33742,"run_id":31042,"accession_number":"0001568651-26-000074","anchor_item_number":"7.01","event_type":"financial_other","event_domain":"financial","is_material":true,"confidence":0.85,"summary":"Oscar Health disclosed material improvements to its full year 2026 financial guidance at an Investor Day event, including a 50 basis point improvement in Medical Loss Ratio guidance and a $100 million increase in Earnings from Operations guidance. While this is guidance disclosure rather than actual earnings results, the material upward revisions to forward-looking financial targets would affect a reasonable investor's assessment of the company's financial trajectory and operational performance.","company_name":"Oscar Health, Inc.","ticker":"OSCR","filing_date":"2026-09-16","form":"8-K","submitted_at":null,"items":[{"id":37262,"accession_number":"0001568651-26-000074","item_number":"7.01","item_title":null,"event_type":"financial_other","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"Oscar Health disclosed material improvements to its full year 2026 financial guidance at an Investor Day event, including a 50 basis point improvement in Medical Loss Ratio guidance and a $100 million increase in Earnings from Operations guidance. While this is guidance disclosure rather than actual earnings results, the material upward revisions to forward-looking financial targets would affect a reasonable investor's assessment of the company's financial trajectory and operational performance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-16T10:05:57.041299+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":37262,"accession_number":"0001568651-26-000074","item_number":"7.01","item_title":null,"event_type":"financial_other","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"Oscar Health disclosed material improvements to its full year 2026 financial guidance at an Investor Day event, including a 50 basis point improvement in Medical Loss Ratio guidance and a $100 million increase in Earnings from Operations guidance. While this is guidance disclosure rather than actual earnings results, the material upward revisions to forward-looking financial targets would affect a reasonable investor's assessment of the company's financial trajectory and operational performance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-16T10:05:57.041299+00:00","company_name":"Oscar Health, Inc.","ticker":"OSCR","filing_date":"2026-09-16"}]}